URI
50
7
OI
50
-5
MRK
66
2
GS
72
2
SHW
59
3
COP
47
2
ZBH
47
-12
VNO
44
-2
EXC
51
-3
EQIX
57
3
WDC
61
-3
SYY
53
-3
PNR
63
3
DLTR
63
5
URBN
72
-2
USB
65
6
DTE
43
3
STT
67
2
R
72
5
SLG
45
-3
URI
50
7
OI
50
-5
MRK
66
2
GS
72
2
SHW
59
3
COP
47
2
ZBH
47
-12
VNO
44
-2
EXC
51
-3
EQIX
57
3
WDC
61
-3
SYY
53
-3
PNR
63
3
DLTR
63
5
URBN
72
-2
USB
65
6
DTE
43
3
STT
67
2
R
72
5
SLG
45
-3
Financhill
Back

Iovance Biotherapeutics, Inc. 10K Form

Sell
24

IOVA
Iovance Biotherapeutics, Inc.

Last Price:
$2.20
Seasonality Move:
8.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IOVA News And Ratings

See the #1 stock for the next 7 days that we like better than IOVA

IOVA Financial Statistics

Sales & Book Value

Annual Sales: $164.1M
Cash Flow: $-89.5M
Price / Cash Flow: 0
Annual Sales: $1.82
Price / Book: 1.25

Profitability

EPS (TTM): -1.20200
Net Income (TTM): $-397.6M
Gross Margin: $17.7M
Return on Equity: -54.43%
Return on Assets: -42.48%

Iovance Biotherapeutics, Inc. Earnings Forecast

Key Iovance Biotherapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 17 years for IOVA is 10.77%.
  • The Selling, General & Administrative Expenses for IOVA have been equal to 93.26% of Gross Profit Margin.
  • The Research & Development expenses have been 172.08% of Revenue.
  • The Net Earning history of IOVA is -226.84% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 8 years.

Iovance Biotherapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IOVA
CUSIP: 462260
Website: iovance.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 3.41
Quick Ratio: 2.92

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IOVA Technical Analysis vs Fundamental Analysis

Sell
24
Iovance Biotherapeutics, Inc. (IOVA) is a Sell

Is Iovance Biotherapeutics, Inc. a Buy or a Sell?